Clinical Trial Update: Open-Label, Dose-Escalation With Expansion to Assess the Safety, Tolerability, and PK of TRE-515 in Subjects With Solid Tumors [Phase 1]

View source ↗

Summary

An open-label Phase 1 trial of TRE-515 in adults with solid tumors to assess safety, tolerability, and pharmacokinetics with dose-escalation and expansion cohor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• TRE-515

Snippet

Sponsor: Trethera | Conditions: Solid Tumor, Adult, Oncology | Phase 1 | Status: RECRUITING